Effects of anti-secretory factor (ASF) on irritable bowel syndrome (IBS)

References

• Oddsson E, Rask-Madsen J, Krag E. A secretory epithelium of the small intestine with increased sensitivity to bile acids in irritable bowel syndrome associated with diarrhoea. Scand J Gastroenterol 1978; 13: 408–16
   PubMed Web of Science ®Google Scholar
• Agréus L, Svärdsudd K, Nyrén O, et al. Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time. Gastroenterology 1995; 109: 671–80
   PubMed Web of Science ®Google Scholar
• Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999; 45: 1–15
   PubMed Web of Science ®Google Scholar
• Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorder and functional abdominal pain. Gut 1999; 45: 43–7
   Web of Science ®Google Scholar
• Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in post-infective gut dysfunction. Gut 1999; 44: 400–6
   PubMed Web of Science ®Google Scholar
• Young E, Stoneham MD, Petruckevitch A, et al. A population study of food intolerance. Lancet 1994; 343: 1127–30
   PubMed Web of Science ®Google Scholar
• Svedlund J, Sjödin I, Dotevall G, et al. Upper gastrointestinal and mental symptoms in the irritable bowel syndrome. Scand J Gastroenterol 1985; 20: 595–601
   PubMed Web of Science ®Google Scholar
• Simrén M, Abrahamssom H, Björnsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 2001; 1: 20–2
   Google Scholar
• Sjölund K, Ekman R. Disturbed motilin and cholecystokinin release in the irritable bowel disease. Scand J Gastroenterol 1996; 31: 1110–14
   PubMed Web of Science ®Google Scholar
• Jones VA, McLaughlan P, Shorthouse M, et al. Food intolerance: A major factor in the pathogenesis of irritable bowel syndrome. Lancet 1982; 2: 1115–17
   PubMed Web of Science ®Google Scholar
• Simrén M, Månsson A, Langkilde AM, et al. Food-related gastrointestinal symptom in the irritable bowel syndrome. Digestion 2001; 63: 108–15
   PubMed Web of Science ®Google Scholar
• Dainese R, Galliani EA, De Lazzari F, et al. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999; 94: 1892–7
   PubMed Web of Science ®Google Scholar
• Poitras P, Poitras MR, Plourde V, et al. Evolution of visceral sensitivity in patients with irritable bowel syndrome. Dig Dis Sci 2002; 47: 914–20
   PubMed Web of Science ®Google Scholar
• Chaudhary NA, Truelove SC. The irritable colon syndrome. QJM 1962; 31: 307–22
   PubMed Web of Science ®Google Scholar
• Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. BMJ 1997; 314: 779–82
   PubMed Web of Science ®Google Scholar
• Lunn PG, Northrop-Clewes CA, Downes RM. Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet 1991; 338: 907–10
   PubMed Web of Science ®Google Scholar
• Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: An overview. Gastroenterology 1995; 108: 1566–81
   PubMed Web of Science ®Google Scholar
• Collins SM, Piche T, Rampal P. The putative role of inflammation in the irritable bowel syndrome. Gut 2001; 49: 743–5
   PubMed Web of Science ®Google Scholar
• Lönnroth I, Lange S. Purification and characterization of a hormone-like factor which inhibits cholera secretion. FEBS Lett 1984; 177: 104–8
   PubMed Web of Science ®Google Scholar
• Lange S, Lönnroth I, Skaldhauge E. Effects of the antisecretory factor in pigs. Pflugers Arch 1987; 409: 328–32
   PubMed Web of Science ®Google Scholar
• Lange S, Martinsson K, Lönnroth I, et al. Plasma level of antisecretory factor (ASF) and its relation to post-weaning diarrhoea in piglets. J Vet Med B 1993; 40: 113–18
   Google Scholar
• Björck S, Bosaeus I, Ek E, et al. Food-induced stimulation of the antisecretory factor improves symptoms in human inflammatory bowel disease. A study of a concept. Gut 2000; 46: 824–82
   PubMed Web of Science ®Google Scholar
• Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care 1992; 30: 473–83
   PubMed Web of Science ®Google Scholar
• Camilleri M, Choi M-G. Review article: Irritable bowel syndrome. Aliment Pharmacol Ther 2002; 48: 272–82
   Google Scholar
• Akehurst R, Kaltenthaler E. Review: Treatment of irritable bowel syndrome: A review of randomised controlled trials. Gut 2001; 48: 272–82
   PubMed Web of Science ®Google Scholar
• Prior A, Whorwell PJ. Double-blind study of ispaghula in irritable bowel syndrome. Gut 1987; 28: 1510–3
   PubMed Web of Science ®Google Scholar
• Snook J, Shepherd HA. Bran supplementation in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 511–14
   PubMed Web of Science ®Google Scholar
• Lucey MR, Clark ML, Lowndes J, et al. Is bran efficacious in irritable bowel syndrome? A double-blind placebo-controlled crossover study. Gut 1987; 28: 221–5
   PubMed Web of Science ®Google Scholar
• Spiller RC. Problems and challenges in the design of IBS trials, Part I: A review of the experience from published trials. Am J Gastroenterol 1999; 107: 915–75
   Google Scholar
• Klein KB. Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterology 1988; 95: 232–41
   PubMed Web of Science ®Google Scholar